A Phase Ib/II Trial of Capmatinib Plus Spartalizumab Vs. Spartalizumab Alone in Patients with Pretreated Hepatocellular Carcinoma
JHEP REPORTS（2024）
关键词
Capmatinib,Spartalizumab,Hepatocellular carcinoma,MET,anti-programmed death-ligand 1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要